Garren believes diabetes to be a market just as large as that for cancer.
FORBES: Beware Of Biotechs At Cancer-Cure Prices
"There are real products in late-stage trials producing real results, " observes Dr. Ron Garren, an oncologist in California and editor of Biotech Insight.
"I wouldn't buy it here, but I wouldn't short it either, " says Garren, noting the extremes to which biotechs can go on the upside and the downside.
应用推荐
模块上移
模块下移
不移动